Log In
Print
BCIQ
Print
Print this Print this
 

sNN0029

  Manage Alerts
Collapse Summary General Information
Company Newron Pharmaceuticals S.p.A.
DescriptionVascular endothelial growth factor (VEGF) protein
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationAmyotrophic lateral sclerosis (ALS)
Indication DetailsTreat amyotrophic lateral sclerosis (ALS)
Regulatory Designation

Partner

Roche


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today